A randomized, placebo-controlled Phase 1 clinical trial of two monoclonal antibodies (mAbs) directed against the coronavirus that causes Middle Eas
Headlines for Middle East Respiratory Syndrome
Powered By Bing News
Background The COVID-19 has had an enormous impact worldwide and is still spreading.
A randomized, placebo-controlled Phase 1 clinical trial of two monoclonal antibodies (mAbs) directed against the coronavirus that causes Middle Eas
A randomized, placebo-controlled Phase 1 clinical trial of two monoclonal antibodies (mAbs) directed against the coronavirus that causes MERS found
In August last year, the results of a nationwide analysis of the impact of Covid on people with diabetes was published.
INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat
PLYMOUTH MEETING, Pa., Feb. 23, 2021 /PRNewswire via COMTEX/ -- PLYMOUTH MEETING, Pa., Feb. 23, 2021 /PRNewswire/ -- INOVIO (NASDAQ:INO), a
CoV-2, variants found to date may differ only slightly from canonical published sequences, and so open analysis of patent applications disclosing v
Taken within 3 days of presentation. ‡Antibodies against Middle East respiratory syndrome coronavirus. §Symptomatic but refused hospitalization.
A growing chorus of researchers say now is the time to invest in coronavirus vaccine development and treatments to stop the next pandemic to come.
A new study looking at how COVID-19 affects people with asthma provides reassurance that having the condition doesn't increase the risk of sev
Smiths Detection reports that its BioFlash® Biological Identifier is capable of detecting SARS-CoV-2 (COVID-19) in the air following tests conducte
Preclinical development of and research on potential Middle East respiratory syndrome coronavirus (MERS-CoV) medical countermeasures remain prelimi
In October 2012 and April 2013, three agencies collected samples from bats in regions where MERS cases had been identified (Figure 1).
A new study looking at how COVID-19 affects people with asthma provides reassurance that having the condition doesn't increase the risk of sev
A review of 57 studies shows people with asthma had a 14 percent lower risk of getting COVID-19 and were significantly less likely to be hospitaliz
USAMRIID confirms Smiths Detection’s BioFlash Biological Identifier capable to detect airborne Covid-19: London Friday, February 19, 2021, 13:00 Hr
We ask experts in the fields of medicine, biology, public health, education, religion about the unexpected upsides in the coronavirus pandemic.
We ask experts in the fields of medicine, biology, public health, education, religion about the unexpected upsides in the coronavirus pandemic.
The prestigious journal Science on Thursday published an editorial calling for a global effort to develop a universal coronavirus vaccine that woul
Vaccination combined with physical distancing can suppress resurgences without relying on stay-at-home restrictions.
The researchers predicted many more associations between coronaviruses and host species than have been observed to date.
Emitbio Inc., a life science company developing light-based therapies, is seeking emergency use authorization (EUA) from the U.S.
Emitbio Inc., a life science company developing light-based therapies, is seeking emergency use authorization (EUA) from the U.S.
To the Editor: Assiri et al. (Aug.
Lab accident hypothesis, though “extremely unlikely,” has not been ruled out, Peter Ben Embarek says after returning from 4-week investigation
The allegations of biowarfare surrounding this pandemic should prompt a review of the Biological Weapons Convention and states’ compliance with it.
It is essential to our health and wellbeing that all of us understand the facts about COVID-19… what it is and what it isn’t.
A new paper, in the journal Microbiology research, deals with the perceived and actual delivery of food items during this period.
Smiths Detection, a global leader in threat detection and security screening technologies, today reports that its BioFlash® Biological Identifier i
Suwon Mayor Yeom Tae-young’s “Special City Operation” was a success.
Hundreds of mammal species could serve as incubators for coronaviruses to mix and match with one another, potentially forming new viruses and fueli
As the exact zoonotic origin of SARS-CoV-2 remains unresolved, scientists at the Francis Crick Institute in London, UK, explored the structure and
Most of the country is dealing with a historic cold snap and winter storm, leaving millions without power as arctic temperatures continue to grip m
Steve Bates' phone rang.
Lab accident hypothesis, while 'extremely unlikely,' has not been ruled out, says Peter Ben Embarek after returning from 4-week investiga
Middle East Respiratory Syndrome (MERS) is a new disease in humans. The first recorded cases were in Saudi Arabia in 2012.
After several months of delay, concerns over access, and bickering between China and the U.S., a 17-member team from the World Health Organisation
Just weeks into the rollout of vaccines to combat Covid-19, researchers are shifting their focus to a new class of potential shots to take on the t
Throughout the history of evolution, and even through the history of mankind, you’ve seen species get wiped out.
An efficient treatment against a COVID-19 disease, caused by the novel coronavirus SARS-CoV-2 (CoV2), remains a challenge.
An efficient treatment against a COVID-19 disease, caused by the novel coronavirus SARS-CoV-2 (CoV2), remains a challenge.
Japan's national healthcare system, which has the most hospital beds in the developed world per capita, has been praised in the past for its h
A year after masks began to blossom on the streets of some cities -- and not in others -- in response to the Covid-19 crisis, guidance over how bes
Breastfeeding women with COVID-19 do not pass along the SARS-CoV-2 virus in their milk but do transfer milk-borne antibodies that are able to neutr
The invention of COVID-19 vaccines will be remembered as a milestone in the history of medicine, creating in a matter of months what had before tak
Researchers are starting to develop prototypes of a so-called pancoronavirus vaccine, with some promising, if early, results from experiments on an
Researchers in China have developed three SARS-CoV-2 nanoparticle vaccines, containing receptor-binding domain (RBD) trimer, S1 trimer, and ectodom
The drug was tested in human lung tissue implanted into mice. It has entered Phase 2 and Phase 3 clinical trials.
From doubts about safety in older people to questions about variants, scientists have faced a battle to convince the public and regulators